Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.817
-0.003 (-0.16%)
May 1, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $22.37 million as of May 1, 2026. Its market cap has decreased by -55.83% in one year.
Market Cap
22.37M
Enterprise Value
22.64M
1-Year Change
-55.83%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $22.37M, a decrease of -82.12%. That is a compound annual growth rate of -56.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 22.37M | 9.68% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 24.79M |
| Marker Therapeutics | 24.34M |
| Lantern Pharma | 23.76M |
| Curis | 23.67M |
| AEON Biopharma | 22.52M |
| Quince Therapeutics | 21.68M |
| VYNE Therapeutics | 21.37M |
| OSR Holdings | 21.09M |